Identification of Novel Markers of Human Lung Disease
NCT02369575 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-07-29
Summary
The purpose of this study is to investigate new therapies for advanced lung disease.
Conditions
- Lung Diseases, Interstitial
Interventions
- OTHER
-
novel biomarkers of lung disease
we will be identifying molecular, genetic, and cellular markers of lung disease
Sponsors & Collaborators
-
Ohio State University
lead OTHER
Principal Investigators
-
Megan Ballinger · Ohio State University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarker in Lung Diseases
NCT00989846 ·Status: UNKNOWN
-
Novel Biomarkers in Chronic Airway Diseases
NCT00849836 ·Status: UNKNOWN
-
Image and Model Based Analysis of Lung Disease
NCT03764163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Breath Analysis in Children by New Point-of-care Instruments
NCT03377686 ·Status: COMPLETED
-
Imaging Lung Function Using Oxygen Enhanced MRI
NCT01731015 ·Status: COMPLETED ·Phase: PHASE1
-
Detection of Early Idiopathic Pulmonary Fibrosis
NCT03457935 ·Status: ACTIVE_NOT_RECRUITING
-
Pulmonary Fibrosis Lung Sounds Study
NCT05771740 ·Status: UNKNOWN
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
NCT00001462 ·Status: COMPLETED
-
COPD Exacerbation Blood and Urine Biomarkers Study
NCT03823443 ·Status: TERMINATED
-
Evaluation of the Causes and Disease Processes of Chronic Lung Disease
NCT00001183 ·Status: COMPLETED
-
Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
NCT00212511 ·Status: WITHDRAWN
-
Genentech Validation Tool for Pulmonary Fibrosis
NCT04676594 ·Status: ACTIVE_NOT_RECRUITING
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
NCT00258544 ·Status: ACTIVE_NOT_RECRUITING
-
Study on Screening Strategies for Interstitial Lung Abnormalities and Airway Lesions
NCT07023575 ·Status: NOT_YET_RECRUITING
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
Advancing Prevention of Pulmonary Fibrosis
NCT04564183 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
NCT06323876 ·Status: RECRUITING
-
Symptom Clusters and Immune Markers in Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Longitudinal Study
NCT01016587 ·Status: COMPLETED
-
Role of Genetic Factors in the Development of Lung Disease
NCT00001532 ·Status: RECRUITING
-
2014TP001 - Assessing the Biology of the Injured Lung - Version 1
NCT05978011 ·Status: COMPLETED
-
Novel Markers of Disease Progression in Interstitial Lung Disease
NCT05760508 ·Status: UNKNOWN
-
Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
NCT01718990 ·Status: COMPLETED
-
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
NCT00655694 ·Status: WITHDRAWN